| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nemolizumab fda | 1.16 | 0.7 | 7955 | 64 | 15 |
| nemolizumab | 1.86 | 0.5 | 1454 | 100 | 11 |
| fda | 1 | 0.1 | 8348 | 51 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nemolizumab fda approval | 0.88 | 0.8 | 6321 | 13 |
| nemolizumab fda | 0.96 | 0.2 | 1806 | 69 |
| nemolizumab fda approval atopic dermatitis | 1.73 | 0.1 | 4549 | 23 |
| nemolizumab for atopic dermatitis | 0.92 | 0.9 | 5319 | 81 |
| nemolizumab adolescent atopic dermatitis | 1.62 | 0.1 | 941 | 62 |
| fda approval atopic dermatitis | 1.52 | 1 | 7106 | 21 |
| ruxolitinib atopic dermatitis fda approval | 1.38 | 0.6 | 5702 | 40 |
| atopic dermatitis fda approved drugs | 1.74 | 0.6 | 3396 | 94 |
| ruxolitinib atopic dermatitis approval | 0.52 | 0.1 | 5171 | 55 |
